Mural Oncology plc (MURA)

Mural Oncology plc is a pioneering biotechnology company dedicated to developing targeted therapies for solid tumors, addressing significant unmet needs in oncology. The company utilizes proprietary platforms to boost immune system engagement, advancing a strong pipeline of innovative drug candidates designed to enhance patient outcomes. With a strategic focus on clinical excellence and collaborative partnerships, Mural is committed to delivering transformative precision medicine solutions that elevate cancer care and set new benchmarks in treatment efficacy.